Trending Now
Stocks Making The Biggest Move Pre Market (MGRX,AMD,GIS,PINS,SNOW,ZI)
S&P 500 futures inched lower Wednesday as traders digested a broad market rally in the previous session. Before we get into the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Cidara Therapeutics Inc. (NASDAQ: CDTX) and Mundipharma Report Positive ReSTORE Phase...
Cidara Therapeutics Inc. (NASDAQ: CDTX) and Mundipharma have announced topline results from the vital ReSTORE third phase clinical study evaluating the safety and efficacy...
MAKE IT MODERN
LATEST REVIEWS
Why the Latest GCGX Move Could Spark Fresh Interest
Global Consortium Inc. (OTCMKTS:GCGX) is making waves again, with shares pushing off recent basing lows to kick off the holiday-shortened week. The...
MAKE IT MODERN
PERFORMANCE TRAINING
XPeng Inc (NYSE:XPEV) could be the dark horse in the EV race
Chinese stocks are gapping higher this morning and unlike U.S tech stocks so far are holding those gains.
The...
Sorrento Therapeutics Inc. (NASDAQ:SRNE) Receives $34 Million Government Contract For Development Of COVID-19 Treatment
Sorrento Therapeutics Inc. (NASDAQ:SRNE) has received a $34 million government contract to manufacture COVID-19 neutralizing antibodies. Through its SmartPharm Therapeutics subsidiary, the company received...
The Coronavirus Coping Portfolio (QDEL, GILD, QBIO, CYDY)
The COVID-19 pandemic has forced a dramatic realignment of social, cultural, and economic agendas because, in all cases, the healthcare issue has...
SOBR Safe Inc. (SOBR) storms Wall Street with over 60% gains
Shares of BOBR Safe Inc (NASDAQ:SOBR), a provider of top-notch alcohol screening solutions, closed the day at $1.8000 with a gain of...
Evofem Biosciences Inc (NASDAQ:EVFM) Kicks Off Its EVO100 Phase 3 Trial With First Patient...
Evofem Biosciences Inc (NASDAQ:EVFM) recently announced the dosing of the first patient in its phase 3 clinical trial to evaluate its preventative therapy for...























































